Logo

Glaxosmithkline Phar Share Price

Glaxosmithkline Phar (INR)2190.4-17.9   (-0.8%)

Exchange ScripsBSE500660NSEGLAXOISININE159A01016

Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks

Trendline of performance -

Glaxosmithkline Phar Performance

Market performance
Open price2208.35
High2213.9
Volumes89191
Prev Close2190.4
Low2141.35
Closing date2025-01-10
Historical performance
1 Year High3088.00
3 Year High3088.00
5 Year High3088.00
1 Year Low1842.05
3 Year Low1227.00
5 Year Low962.65

Glaxosmithkline Phar Fundamentals

Company Valuation
Market Cap
Market Cap (₹Cr)
37107
Face Value
Face Value (₹)
10
P/E Ratio
P/E Ratio
62.9
Dividend Yield
Dividend Yield
0.15 %

Glaxosmithkline Phar Investment Returns

1 Year
-0.5%
3 Years
24.3%
5 Years
34.6%
10 Years
37.2%

Glaxosmithkline Phar Technicals

IndicatorsValueSignal
5-DMA2207.79Bearish
10-DMA2217.14Bearish
20-DMA2248.44Bearish
50-DMA2379.56Bearish
100-DMA2571.12Bearish
200-DMA2479.6Bearish

Shareholding Pattern

FieldSep-2024Jun-2024Mar-2024Dec-2023Sep-2023
Promoters44444
Foreign Investors44444
Domestic Investors---------------
Public Investors119224118511118990114659115264
Government22233

Glaxosmithkline Phar Financials

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Other Income122610077581106
Operating Profit10313904983777087
Interest18182035
Depreciation697658682786
Profit Before Tax8162836477904540
Consolidated Net Profit59006107169473581
Adjusted EPS353610021

Balance Sheet

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Share Capital1694169416941694
Total Reserves16172157352493513089
Minority Interest------------
Total Non-Current Liabilities1077125415871787
Total Liabilities34103319304520130115
Capital Work in Progress139203305132
Total Assets34103319304520130115

Cash Flow

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Cash Flow from Operating Activities5820484281075779
Cash Flow from Investing Activities878079-40554180
Cash Flow from Financing Activitie-5615-15433-5242-6956
Net Cash Inflow / Outflow292-2512-11903004
0%
Negative
Neutral
Positive
  • The stock has a PE ratio of 62.9.
  • 3Y Stock Price CAGR of the stock is 7.3.
  • The stock has a beta of 0.5.
  • In the last financial year, the company had an EBITDA of ₹10313 Million.
  • The company generated revenue of ₹34537 Million in the previous financial year.

Glaxosmithkline Phar

2190.4-17.9   (-0.8%)

Investment Amount: ₹ 225920
Current Value: ₹ 219040
Performance: -3%
P/L: ₹ -6880
Top Gainers
SymbolChange%
NURECA380.7(18%)
CUBEXTUB96.84(16%)
MAZDA1969.9(14%)
ATLASCYCLE112.81(10%)
DNAMEDIA6.99(10%)
Top Losers
SymbolChange%
GTPL130.53(-11%)
GRWRHITECH4286.15(-10%)
SPANDANA405.8(-10%)
JAICORPLTD173(-10%)
AWL291.1(-10%)
DISHTV8.86(-10%)
HARRMALAYA284.45(-9%)
KAMDHENU46.4(-9%)
Similar stocks

Zota Health Care

52.3

994.45

December 12 - January 12

Medico Remedies

28.3

63.14

December 12 - January 12

Brooks Laboratories

26.2

182.06

December 12 - January 12

Bajaj Healthcare

18.8

536.65

December 12 - January 12

Nectar Lifesciences

14.3

38.25

December 12 - January 12

SMS Lifesciences

13.8

1301.8

December 12 - January 12

Blue Jet Healthcare

13.5

571.5

December 12 - January 12

Aarti Pharmalabs

10.5

669.5

December 12 - January 12

Announcing Stock of the Month!

Stock of the Month
Stock of the Month